RecruitingNot Applicable

A Natural History Study of Angelman Syndrome

United States40 participantsStarted 2026-06

Plain-language summary

The goal of this observational study is to learn about the natural progression of Angelman syndrome (AS) in children and adults with a confirmed genetic diagnosis of AS. The main questions it aims to answer are: * How do developmental skills, such as communication, motor abilities, and adaptive behaviors, change over a 1-year period in people with AS? * Are there specific patterns in brain activity or sleep that are associated with changes in AS symptoms over time? Participants will: * Visit the study site 5 times over 1 year (approximately every 3 months) for assessments. * Complete tests and questionnaires about development, behaviors, and sleep with the help of their caregivers. * Undergo electroencephalograms (EEGs) to measure brain activity and wear a sleep-monitoring device at home (to collect actigraphy data).

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The participant has a primary clinical diagnosis of Angelman syndrome with documented genetic variation(s) affecting the function of the UBE3A gene within the human 15q11.2-q13.3 locus. Co-occurring conditions (e.g., autism spectrum disorder, cerebral palsy, intellectual disability) are permitted; however, Angelman syndrome must be the primary clinical diagnosis. * The participant is male or female (assigned sex at birth) and aged ≥1 year at the initial study visit. * The participant has a study partner who meets the study partner criteria below. * The participant, if unable to provide informed consent, has an appropriate surrogate who is at least 18 years of age and willing and able to provide informed consent on behalf of the participant in accordance with current International Council for Harmonisation (ICH) guidelines and applicable institutional regulations. Individuals must satisfy the following criteria to be enrolled as study partners: * The study partner is a parent or primary caregiver who is at least 18 years of age. * The study partner has consistent contact with the participant and, in the opinion of the investigator, is sufficiently knowledgeable about the participant's ongoing condition to provide accurate and current information. * The study partner has sufficient English-language proficiency to complete study partner assessments. * The study partner is willing and able to provide informed consent on their own behalf in accordance with…

What they're measuring

Change from Baseline in Bayley Scale of Infant Development, Fourth Edition (Bayley-4) Cognitive Growth Score Equivalent at 12 Months

Timeframe: Baseline, 3 months, 6 months, 9 months, and 12 months

Change from Baseline in Bayley Scale of Infant Development, Fourth Edition (Bayley-4) Receptive Communication Growth Score Equivalent at 12 Months

Timeframe: Baseline, 3 months, 6 months, 9 months, and 12 months

Change from Baseline in Bayley Scale of Infant Development, Fourth Edition (Bayley-4) Expressive Communication Growth Score Equivalent at 12 Months

Timeframe: Baseline, 3 months, 6 months, 9 months, and 12 months

Change from Baseline in Bayley Scale of Infant Development, Fourth Edition (Bayley-4) Fine Motor Growth Score Equivalent at 12 Months

Timeframe: Baseline, 3 months, 6 months, 9 months, and 12 months

Change from Baseline in Bayley Scale of Infant Development, Fourth Edition (Bayley-4) Gross Motor Growth Score Equivalent at 12 Months

Timeframe: Baseline, 3 months, 6 months, 9 months, and 12 months

Trial details

NCT IDNCT07417137

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-09

Contact for this trial

Colleen G Buckless

781-860-1711 MGHGLOW-AS@mgb.org

View on ClinicalTrials.gov More Angelman Syndrome trials